Research shows that a weight loss drug may trigger a false positive on an ignition interlock breath test. In a 2026 case report, a woman had two positive results within days of raising her Wegovy dose from 1.0 mg to 1.7 mg, though she denied drinking. The likely cause may be isopropanol made by the body.
According to research reviewed by Gram, a woman taking the weight loss drug Wegovy had two positive results on a car breath alcohol test, called an ignition interlock, within days of a dose increase, even though she said she had not been drinking. The case report, published in 2026 in The Medico-legal Journal, suggests that eating less after the dose increase may have pushed her body to burn more fat. That process can create acetone, a natural chemical, which may then be converted into isopropanol, a type of alcohol found in products like rubbing alcohol. Some breath testers can mistake isopropanol for drinking alcohol. The report describes only one person, so it cannot prove what happened in every case. It does point to a possible explanation that device operators, courts, and people using these medications should consider when reviewing disputed results.
Key Statistics
A 2026 case report published in The Medico-legal Journal described a 45-year-old woman who recorded two positive ignition interlock breath alcohol results within days of increasing her Wegovy dose from 1.0 mg to 1.7 mg.
According to research reviewed by Gram, the case report involved a single participant, and the authors proposed that a body-made alcohol called isopropanol may have caused the false positive readings.
The Quick Take
- What they studied: Can a common weight loss medicine, called a GLP-1 drug, cause a car breath alcohol device to falsely show that someone has been drinking?
- Who participated: One woman, age 45, who was prescribed Wegovy. She said she had not been drinking, had been sober for several years, kept her job, and followed the rules of her ignition interlock device.
- Key finding: After her Wegovy dose went up from 1.0 mg to 1.7 mg, the device gave two positive alcohol readings within a few days. The authors suggest a chemical made by her body, not alcohol she drank, may have caused the readings. Because this is a single case, the finding shows a possibility, not a proven cause.
- What it means for you: If you use a GLP-1 medicine and have an ignition interlock device, a positive reading does not automatically mean you drank. Eating much less food can change your body chemistry in ways that may affect the device. Talk with your prescriber and device provider if you get an unexpected result.
The Research Details
This was a case report, which means the authors carefully described the experience of one person rather than testing a large group. They looked at the woman’s medical history, her medication schedule, her food intake changes, and the timing of her breath test results. They also reviewed the device’s records and her court testimony.
The authors focused on a known feature of the device. Ignition interlock devices use a small electrochemical sensor, called a fuel cell, that reacts to alcohol in breath. These sensors are designed to detect ethanol, the alcohol in drinks, but they can also react to isopropanol, a different alcohol. The authors then linked this to a possible chain of body chemistry changes that could produce isopropanol.
Because the design is a detailed look at one case, it is useful for spotting unusual possibilities. It is not designed to show how often this happens or to prove cause and effect.
Case reports are often the first step in spotting problems that larger studies have not yet noticed. A detailed story like this can alert doctors, device companies, and legal professionals to a new possibility that deserves further testing. It also gives a clear chain of possible steps that researchers can check in future studies.
This report has the strengths of careful detail, a clear timeline, and a plausible scientific explanation that matches earlier reports about ketone-producing diets and other conditions. It also has clear limits. It includes only one person, has no control group, and does not measure the woman’s body chemistry directly in the way a controlled study would. The explanation is a hypothesis that still needs testing. The journal’s impact level is not confirmed here, so readers should weigh it as an early-stage report.
What the Results Show
The main result was that the woman’s breath test showed alcohol twice within days of her Wegovy dose increase, even though she denied drinking. Her records and testimony supported the claim that she had not consumed alcohol. This sets up the central question of whether something other than alcohol caused the readings.
The authors suggest that eating less after the dose increase may have shifted her body toward burning fat for energy. When the body burns fat, it can produce ketone bodies, including acetone. The authors propose that some of this acetone may have been converted into isopropanol. Isopropanol is a chemical that can be present in the body in small amounts under certain conditions.
The key concern is that a fuel-cell sensor may react to isopropanol in a way similar to ethanol. If enough isopropanol reaches the sensor through the breath, the device can show an apparent alcohol result. This explains how a person who has not had a drink could still fail a test.
The authors stress that this is one plausible explanation rather than a confirmed cause. They do not provide a measured percentage of how often this happens, and they do not show that the same effect would occur in every person taking GLP-1 medicines.
The report notes that the woman maintained steady employment and followed her device requirements. These details matter because they make a simple explanation of intentional drinking less likely, although they do not prove the readings were false. The report also highlights how a dose change, combined with lower food intake, can change body chemistry in ways that people do not expect. For device users and reviewers, this means that a timeline of medicine changes and eating habits may be as important as the test result itself.
Earlier reports have described false positive breath alcohol results in people with raised ketone levels. These include a person following a very-low-calorie ketogenic diet and a person with diabetic ketoacidosis, a serious complication of diabetes. This case extends that pattern to a person taking a GLP-1 medicine after a dose increase. It fits with what is known about how reduced calorie intake can drive the body to make more ketones and acetone.
The biggest limitation is the sample size: the report describes one person. A single case cannot show how common this effect is or whether it would happen in other people taking Wegovy or similar medicines. The authors did not directly measure isopropanol or acetone levels in this woman’s breath or blood in a controlled way, so the chain of events is still a well-reasoned guess. Other explanations, including device error or other substances, were not fully ruled out in this report. Future studies with larger groups and direct chemical measurements are needed.
The Bottom Line
Research shows that ketone-producing diets can cause some breath alcohol devices to give false positive readings in earlier reports, and this case suggests the same chemistry may apply during GLP-1 medicine use. Confidence is low to moderate because this is a single case report. People who use these medicines and have ignition interlock devices should keep a log of dose changes, meals, and any unexpected results, and should talk with their prescriber and device provider promptly.
People taking GLP-1 medicines such as Wegovy who must use an ignition interlock device should pay attention. Device operators, attorneys, judges, and probation officers who review disputed results should also consider this possibility. People who do not use these medicines or devices can skip this, though the broader lesson about body chemistry and sensors is still interesting.
This is a report about a possible reaction, so there is no set timeline for benefits or changes. In the case described, the readings appeared within days of a dose increase. Anyone who notices a pattern should track changes over the first few weeks after a dose change and seek guidance early instead of waiting for a problem to build up.
Frequently Asked Questions
Can Wegovy cause a false positive on a breathalyzer test?
A 2026 case report suggests it may. One woman taking Wegovy had two positive ignition interlock results within days of a dose increase, although she said she had not been drinking. The authors proposed that a body-made chemical may have caused the readings, but this needs larger studies to confirm.
Why would eating less cause an ignition interlock device to read positive?
Eating much less may push the body to burn fat, which can make acetone. Some acetone may convert into isopropanol, a different alcohol. Breath sensors can react to isopropanol, which may produce a positive reading even when no alcohol was consumed.
What should I do if my ignition interlock test is positive but I have not been drinking?
Record the result along with your medicine doses, meals, and any alcohol-based products used that day. Contact your device provider and prescriber promptly, and share your records with your legal representative if the result is disputed.
Is a single case report enough to prove that GLP-1 drugs affect breath alcohol tests?
No, a single case report cannot prove a cause. It describes one person with a plausible explanation. Research shows that ketone-producing diets have caused similar false readings before, so the idea deserves testing in larger, controlled studies.
Want to Apply This Research?
- Record each Wegovy dose change, the date, your daily meal count or estimated calories, and the time and result of every ignition interlock test. Flag any test that is positive or close to the limit so you can compare it with your eating pattern.
- If your food intake drops sharply after a dose increase, set a reminder to check in with your care team about meal planning. Avoid using hand sanitizers or other alcohol-based products shortly before a breath test, and note any products you used that day in your app log.
- Over the long term, keep a monthly summary that links medicine doses, calorie intake trends, and all breath test results. Share this summary with your prescriber and, when needed, with your device provider or legal representative so that disputed results can be reviewed with a clear timeline.
This article summarizes a single case report and is for general information only. It is not medical, legal, or driving advice. The findings describe one possible explanation that has not been confirmed in larger studies. If you take a GLP-1 medicine or use an ignition interlock device, talk with your doctor, pharmacist, and device provider before making changes to your medicine, diet, or device use.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.